The best treatment for high-grade T1 bladder cancer is cystectomy.

The best treatment for high-grade T1 bladder cancer is cystectomy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The best treatment for high-grade T1 bladder cancer is cystectomy. Abstract Text:

Eila C Skinner,Eila C Skinner,

OBJECTIVES: To evaluate the role of initial cystectomy in the management of high-grade T1 bladder cancer. METHODS: A selected review of the literature was performed to evaluate outcomes with intravesical therapy vs. initial cystectomy in this patient population, with a focus on identifying risk factors for failure of conservative therapy. RESULTS: Many studies in the literature fail to include central pathologic review and re-TUR clinical staging, and there are no randomized studies comparing outcomes with these two initial approaches. Retrospective studies of patients with high-grade T1 tumors treated with initial intravesical therapy suggest that approximately 30% of patients will ultimately require cystectomy, and 30% will die of their disease with or without cystectomy. The risk of progression continues for the life of the patient, and late recurrence and progression is common. Initial clinical and pathologic factors can be identified that predict a high risk of progression and are reasonable indicators for initial cystectomy. CONCLUSION: Radical cystectomy can provide a very high cure rate for these patients and should be considered early in the treatment plan.

The best treatment for high-grade T1 bladder cancer is cystectomy. Publishing Authors By Initials

EC Skinner,EC Skinner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The best treatment for high-grade T1 bladder cancer is cystectomy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Urologic oncology

VOLUME: 25

Page Numbers: 523-5

Journal Abbreviation: Urol. Oncol.

ISSN: 1078-1439

DAY: 30

MONTH: 11

YEAR: 2007

The best treatment for high-grade T1 bladder cancer is cystectomy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9805460

The best treatment for high-grade T1 bladder cancer is cystectomy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The best treatment for high-grade T1 bladder cancer is cystectomy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The best treatment for high-grade T1 bladder cancer is cystectomy.

AFFILIATION: Department of Urology, Keck University of Southern California School of Medicine, Los Angeles, CA 90089, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Urol Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The best treatment for high-grade T1 bladder cancer is cystectomy Related Publications

• Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition.
• Approaches to integrating paediatric diabetes care and structured education: experiences from the Families, Adolescents, and Children's Teamwork Study (FACTS).
• Audibility and speech perception of children using wide dynamic range compression hearing AIDS.
• Breastfeeding in the 21st century: overcoming barriers to help women and infants.
• Bronchography.
• CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.
• Changing perspectives on the benefits of newborn screening.
• Cognitive predictors of improvements in adults' spoken word recognition six months after cochlear implant activation.
• Cr10 laparoscopic right hemicolectomy performed during the 'learning curve phase' does not impact on oncological resection.
• Depressive symptoms in young adults: the influences of the early home environment and early educational child care.
• Dynamical effects in line shapes for coupled chromophores: time-averaging approximation.
• Experiencing the genetic body: parents' encounters with pediatric clinical genetics.
• Gs22p protocols for management of bowel obstruction may not improve patient outcomes.
• Health belief model variables as predictors of progression in stage of mammography adoption.
• Inside the emergency department.
• Looking for Skinner and finding Freud.
• No effect of nutrient restriction from gestational days 28 to 78 on immunocytochemically detectable growth hormone-releasing hormone (GHRH) neurons and GHRH receptor colocalization in somatotropes of the ovine female fetus.
• Optimal control design of excitation pulses that accommodate relaxation.
• Positioning of the tracheal tube during surgical tracheostomy.
• Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
• Pump-probe molecular dynamics as a tool for studying protein motion and long range coupling.
• Regulation of the gonadal transcriptome during sex determination and testis morphogenesis: comparative candidate genes.
• Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
• Role of triptolide as an adjunct chemotherapy for ovarian cancer.
• Secondary control critiqued: is it secondary? is it control? Comment on Morling and Evered (2006).
• Spectral diffusion in a fluctuating charge model of water.
• Surgical intervention in children with multiple endocrine neoplasia type 2.
• The best treatment for high-grade T1 bladder cancer is cystectomy.
• Therapeutic Embolization for the Treatment of Recurrent Hemarthrosis After Total Knee Arthroplasty due to an Arteriovenous Fistula.
• Transgenerational epigenetic imprints on mate preference.